Suen, Leslie W.
Lunn, Mitchell R.
Katuzny, Katie
Finn, Sacha
Duncan, Laura
Sevelius, Jae
Flentje, Annesa
Capriotti, Matthew R.
Lubensky, Micah E.
Hunt, Carolyn
Weber, Shannon
Bibbins-Domingo, Kirsten
Obedin-Maliver, Juno http://orcid.org/0000-0002-0945-2842
Funding for this research was provided by:
UCSF National Center of Excellence in Women's Health
Patient-Centered Outcomes Research Institute (PPRN-1501-26848)
Ruth L. Kirschstein NRSA Institutional Training Grant (T32DK007219)
National Institute on Drug Abuse (K23DA039800)
National Institute of Diabetes and Digestive and Kidney Diseases (K12DK111028)
Veterans Affairs Women's Health Clinical Research Fellowship
UCSF Summer Explore Grant
American Academy of Neurology Clinical Training Research Fellowship
Tourette Association of America
Center for California Studies at Sacramento State University
Article History
Received: 5 July 2019
Revised: 23 July 2020
Accepted: 24 July 2020
First Online: 1 September 2020
Compliance with Ethical Standards
:
: Dr. Matthew Capriotti has received a speaker honorarium from the Tourette Association of America. Dr. Annesa Flentje has consulted for HopeLab. Dr. Mitchell Lunn has consulted for Hims, Incorporated, and Folx, Incorporated. Dr. Juno Obedin-Maliver has consulted for Ibis Reproductive Health, Hims, Incorporated, and Folx, Incorporated. The remaining authors have no conflicts of interest to declare.
: Proposals of these studies were approved by the Institutional Review Board at University of California, San Francisco (#15-16116).
: Informed consent was obtained from all individual participants included in the studies.